Tofajak Tofacitinib 5 Mg Tablets

Product Description

Product introduction

Tofajak 5mg Tablet is used to treat moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. It helps decrease pain, tenderness, and swelling in the joints by reducing inflammation. It also helps slow the progression of bone and joint damage.

Tofajak 5mg Tablet may be prescribed by itself or in combination with another medicine. The tablets can be taken with or without food and it is best to take them at the same time each day. Your dose will depend on your condition and what other medicines you are taking. You should use it as your doctor tells you to. Do not stop taking this medicine unless your doctor tells you to because your condition could get worse.

The most common side effects of Tofajak 5mg Tablet include upper respiratory tract infections, headache, diarrhea, and nasopharyngitis. There are other less common side effects, some of them serious, including blood clots and tears in the stomach or intestine wall. These need urgent medical attention. If you have any worries about side effects, talk to your doctor.

You may need blood tests before you are given this medicine and you should not start taking it if you have any kind of infection. Make sure you talk to your doctor before starting treatment if you have or have ever had, tuberculosis, shingles, kidney or liver disease, hepatitis B or C, or blood clots in your legs or lungs. Tofajak 5mg Tablet can make you more likely to get infections or may worsen any current infections so avoid contact with people who have things you might catch (such as chickenpox, measles, flu).

This medicine is not suitable for children under 18 years old and you should not use it if you are pregnant or breastfeeding, unless your doctor feels the benefit is greater than the risk. Your doctor may need to examine you regularly.

Powerful Relief for Inflammatory Conditions

Tofajak Tablets are formulated to manage symptoms of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis by reducing inflammation and alleviating associated discomfort. The active ingredient, tofacitinib, is clinically proven to help patients regain mobility and improve their quality of life.


Simple Oral Administration

Tofajak is designed for convenience, with easy-to-swallow, film-coated tablets. Patients can take the medication with or without food, following the exact dosage prescribed by their physician. This flexibility ensures straightforward integration into daily routines.


Trusted Quality and Approval

Manufactured by Cipla Healthcare in India, Tofajak is approved by DCGI and complies with other global regulatory standards. Each tablet contains 5 mg of tofacitinib and meets stringent quality control measures to ensure patient safety and efficacy.